Table 2. Univariate analysis of the influence of different NLN count on CSS in patients with cervical cancer.

NLN	No.	5-year CCS	χ2	P value	NLN	No.	5-year CCS	χ2	P value
≤0	49	40.8%	160.499	0.000	≤12	3143	85.1%	80.909	0.000
>0	10451	89.6%			>12	7357	91.2%
≤1	173	60.0%	173.818	0.000	≤13	3545	86.1%	57.158	0.000
>1	10327	89.8%			>13	6955	91.0%
≤2	349	68.4%	169.186	0.000	≤14	3937	86.5%	55.397	0.000
>2	10151	90.1%			>14	6563	91.1%
≤3	482	70.4%	214.406	0.000	≤15	4323	86.8%	51.082	0.000
>3	10018	90.3%			>15	6177	91.2%
≤4	670	73.4%	220.302	0.000	≤16	4718	87.0%	50.894	0.000
>4	9830	90.4%			>16	5782	91.3%
≤5	867	75.4%	213.032	0.000	≤17	5093	87.3%	40.925	0.000
>5	9633	90.6%			>17	5407	91.3%
≤6	1135	78.3%	182.842	0.000	≤18	5444	87.5%	44.011	0.000
>6	9365	90.7%			>18	5056	91.3%
≤7	1404	80.2%	149.141	0.000	≤19	5870	87.9%	34.635	0.000
>7	9096	90.8%			>19	4630	91.2%
≤8	1709	81.7%	123.485	0.000	≤20	6202	88.0%	32.770	0.000
>8	8791	90.8%			>20	4298	91.3%
≤9	2059	83.2%	100.117	0.000	≤21	6536	88.1%	28.925	0.000
>9	8441	90.9%			>21	3964	91.4%
≤10	2396	84.1%	90.895	0.000	≤22	6872	88.3%	24.252	0.000
>10	8104	90.9%			>22	3628	91.3%
≤11	2761	84.4%	91.926	0.000	≤23	7141	88.4%	22.362	0.000
>11	7739	91.1%			>23	3359	91.4%